Skip to content

Achieve Life Sciences ACHV Options canceled (in dollars per share)

Options canceled (in dollars per share) at other companies

Ondas, Inc.
 logo
Ondas, Inc. ONDS
$5.42+274%
Xylem logo
XylemXYL
$127.87+13.3%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$15.04
Lesaka Technologies, Inc. logo
Lesaka Technologies, Inc.LSAK
$11.23+184%
USCB Financial Holdings, Inc. logo
USCB Financial Holdings, Inc.USCB
$0-100%
Avanos Medical logo
Avanos MedicalAVNS
$31.83-14.8%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's options canceled (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's options canceled (in dollars per share)?
Achieve Life Sciences (ACHV) reported options canceled (in dollars per share) of $5.37 in Q1 2026.
What does options canceled (in dollars per share) mean?
This metric measures the weighted average exercise price of stock options that were cancelled or expired during the period. It provides insight into the value of equity incentives that are no longer active, helping investors understand the potential overhang of underwater or abandoned options. This is a key indicator of the company's historical equity incentive pricing relative to market performance.